Page 6 - MRS Abstracts March 2023

using the JBI critical appraisal tool. The study protocol was registered in PROSPERO (CRD42023482573).
Results:
In total, 2257 articles were identified, from which 23 studies were included for analysis amounting to a combined sample size of 65 025 patients. The pooled prevalence of diabetes in patients with axSpA was 7.0% (95% CI 5.0-8.0%) which was statistically significant (p=0.00). There was also a significantly higher odds of diabetes in patients with axSpA compared to controls (pooled OR 1.29, 95% CI 1.08-1.55). The funnel plot was symmetric, thereby indicating a low risk of publication bias.
Conclusions:
Our findings indicate that the prevalence of diabetes in patients with axSpA is high. Routine screening for diabetes and lifestyle modifications should be encouraged in this population.
Key points:
1. The prevalence of diabetes in axial spondyloarthritis is high.
2. There should be greater emphasis on routine screening and risk factor management.
References:
Hintenberger R, Affenzeller B, Vladychuk V, et al. Cardiovascular risk in axial spondyloarthritis-a systematic review. Clin Rheumatol 2023; 42: 2621–2633.